Biological activity of coumarin derivatives as anti-leishmanial agents

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Mandlik, Vineetha ^a   Patil, Sohan ^b   Bopanna, Ramanamurthy ^a   Basu, Sudipta ^b   Singh, Shailza ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 (1,3 BENZODIOXOL 5 YL) 6 [[1H PYRROL 2 YLMETHYLENE]AMINO] 2H CHROMENE 2 ONE; 3 (1,3 BENZODIOXOL 5 YL) 6 [[2 FURYLMETHYLENE]AMINO] 2H CHROMEN 2 ONE; ANTILEISHMANIAL AGENT; COUMARIN DERIVATIVE; LIPOSOME; MILTEFOSINE; NANOMATERIAL; UNCLASSIFIED DRUG; [3 (1,3 BENZODIOXOL 5 YL) 2OXO 2H CHROMEN 6 YL ACETATE]; [6 AMINO 3 (1,3 BENZODIOXOL 5 YL) 2H CHROMEN 2 ONE]; ANTIPROTOZOAL AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEDIATED CYTOTOXICITY; CLINICAL EFFECTIVENESS; COMPUTER MODEL; CONTROLLED STUDY; DRUG DETERMINATION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; MTT ASSAY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SCANNING ELECTRON MICROSCOPY; SKIN LEISHMANIASIS; TREATMENT DURATION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DRUG EFFECTS; LEISHMANIASIS, CUTANEOUS;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; COUMARINS; FEMALE; LEISHMANIASIS, CUTANEOUS; LIPOSOMES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED BALB C;

EID: 84992337464     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164585     Document Type: Article

References (33)

1. Haldar AK, Sen P, Roy S. Use of antimony in the treatment of leishmaniasis: current status and future directions. Molecular biology international. 2011.
2. Yardley V, Croft SL. Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis. Antimicrob Agents Chemother. 1997; 41: 752-756. PMID: 9087483
3. Sundar S, Chakravarty J. Paromomycin in the treatment of leishmaniasis. Expert opinion on investigational drugs. 2008; 17: 787-94. doi: 10.1517/13543784.17.5.787 PMID: 18447603
4. Khademvatan S, Gharavi MJ, Rahim F, Saki J. Miltefosine-induced apoptotic cell death on Leishmania major and L. tropica strains. The Korean journal of parasitology. 2011; 49: 17-23. doi: 10.3347/kjp. 2011.49.1.17 PMID: 21461264
5. Paris C, Loiseau PM, Bories C, Bréard J. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrobial agents and chemotherapy. 2004; 48:852-9. doi: 10.1128/AAC.48. 3.852-859.2004 PMID: 14982775
6. Croft SL, Barrett MP, Urbina JA. Chemotherapy of trypanosomiases and leishmaniasis. Trends in parasitology. 2005; 21:508-12. doi: 10.1016/j.pt.2005.08.026 PMID: 16150644
7. Fournet A, Muñoz V. Natural products as trypanocidal, antileishmanial and antimalarial drugs. Current Topics in medicinal chemistry. 2002; 2:1215-37. PMID: 12171582
8. Mishra BB, Kale RR, Singh RK, Tiwari VK. Alkaloids: Future prospective to combat leishmaniasis. Fitoterapia. 2009; 80:81-90. doi: 10.1016/j.fitote.2008.10.009 PMID: 19015012
9. Sauvain M, Gimenez A, Muñoz V, Callapa J, Le Men-Olivier L, Massiot G et al. Bioactive phenolic glycosides from Amburana cearensis. Phytochemistry. 1999; 50:71-4.
10. Oketch-Rabah HA, Lemmich E, Dossaji SF, Theander TG, Olsen CE, Cornett C et al. Two new antiprotozoal 5-methylcoumarins from Vernonia brachycalyx. Journal of Natural Products. 1997; 60:458-61. doi: 10.1021/np970030o PMID: 9170288
11. Brenzan MA, Nakamura CV, Dias Filho BP, Ueda-Nakamura T, Young MC, Côrrea AG et al. Structure-activity relationship of (-) mammea A/BB derivatives against Leishmania amazonensis. Biomedicine & Pharmacotherapy. 2008; 62:651-8.
12. Napolitano HB, Silva M, Ellena J, Rodrigues BD, Almeida AL, Vieira PC et al. Aurapten, a coumarin with growth inhibition against Leishmania major promastigotes. Brazilian journal of medical and biological research. 2004; 37:1847-52. PMID: 15558191
13. Ibrar A, Zaib S, Jabeen F, Iqbal J, Saeed A. Unraveling the Alkaline Phosphatase Inhibition, Anticancer, and Antileishmanial Potential of Coumarin-Triazolothiadiazine Hybrids: Design, Synthesis, and Molecular Docking Analysis. Archiv der Pharmazie. 2016; 349: 553-565 doi: 10.1002/ardp. 201500392 PMID: 27214743
14. Otero E, Vergara S, Robledo SM, Cardona W, Carda M, Vélez ID et al. Synthesis, leishmanicidal and cytotoxic activity of triclosan-chalcone, triclosan-chromone and triclosan-coumarin hybrids. Molecules. 2014; 19:13251-66. doi: 10.3390/molecules190913251 PMID: 25170948
15. Kermani EK, Sajjadi SE, Hejazi SH, Arjmand R, Saberi S, Eskandarian AA. Anti-Leishmania activity of osthole. Pharmacognosy research. 2016; 8: S1. doi: 10.4103/0974-8490.178650 PMID: 27114685
16. Sangshetti JN, Khan FA, Kulkarni AA, Patil RH, Pachpinde AM, Lohar KS et al. Antileishmanial activity of novel indolyl-coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction. Bioorganic & medicinal chemistry letters. 2016; 26: 829-35.
17. Bashir S, Alam M, Adhikari A, Shrestha RL, Yousuf S, Ahmad B et al. New antileishmanial sesquiterpene coumarins from Ferula narthex Boiss. Phytochemistry Letters. 2014; 9:46-50.
18. Irwin JJ, Shoichet BK. ZINC-a free database of commercially available compounds for virtual screening. Journal of chemical information and modeling. 2005 Jan 24; 45(1):177-82. doi: 10.1021/ci049714 PMID: 15667143
19. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced drug delivery reviews. 2012; 64:4-17.
20. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. Journal of medicinal chemistry. 2002; 45:2615-23. PMID: 12036371
21. ROCS; Open Eye Scientific Software:Santa Fe, NM
22. ACD/Chemsketch, version 5.12, Advanced Chemistry Development, Inc., Toronto, ON, Canada, Available: http://WWW.acdlabs.com
23. Field-Based QSAR, version 2014-3, Schrödinger, LLC, New York, NY, (2014).
24. Mallick A, More P, Ghosh S, Chippalkatti R, Chopade BA, Lahiri M et al. Dual drug conjugated nanoparticle for simultaneous targeting of mitochondria and nucleus in cancer cells. ACS applied materials & interfaces. 2015; 7:7584-98.
25. Rasband WS. Image J, version 1.41. Maryland, Bethesda: National Institutes of Health
26. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. The Journal of Immunology. 1981; 126:1614-9. PMID: 7009746
27. Iranshahi M, Arfa P, Ramezani M, Jaafari MR, Sadeghian H, Bassarello C et al. Sesquiterpene coumarins from Ferula szowitsiana and in vitro antileishmanial activity of 7-prenyloxycoumarins against promastigotes. Phytochemistry. 2007; 68:554-61. doi: 10.1016/j.phytochem.2006.11.002 PMID: 17196626
28. Mogana R, Adhikari A, Debnath S, Hazra S, Hazra B, Teng-Jin K et al. The antiacetylcholinesterase and antileishmanial activities of Canarium patentinervium Miq. Bio Med research international. 2014.
29. Sardari S, Mori Y, Horita K, Micetich RG, Nishibe S, Daneshtalab M. Synthesis and antifungal activity of coumarins and angular furanocoumarins. Bioorganic & medicinal chemistry. 1999; 7:1933-40.
30. Montagner C, de Souza SM, Groposo C, Delle Monache F, Smânia EF, Smânia A Jr. Antifungal activity of coumarins. Zeitschrift für Naturforschung C. 2008 Feb 1; 63(1-2):21-8.
31. Saudagar P, Saha P, Saikia AK, Dubey VK. Molecular mechanism underlying antileishmanial effect of oxabicyclo [3.3. 1] nonanones: inhibition of key redox enzymes of the pathogen. European Journal of Pharmaceutics and Biopharmaceutics. 2013 Nov 30; 85(3):569-77. doi: 10.1016/j.ejpb.2013.08.014 PMID: 24002022
32. Shukla AK, Patra S, Dubey VK. Iridoid glucosides from Nyctanthes arbortristis result in increased reactive oxygen species and cellular redox homeostasis imbalance in Leishmania parasite. European journal of medicinal chemistry. 2012 Aug 31; 54:49-58. doi: 10.1016/j.ejmech.2012.04.034 PMID: 22608855
33. Piller NB. A morphological assessment of the stimulatory effect of coumarin on macrophages. British journal of experimental pathology. 1978, 59:93. PMID: 638035